Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07515664 · ClinicalTrials.gov registry record · Phase 4
Vitamin K for Perioperative Warfarin Management
A Phase 4 study, sponsored by University of Michigan.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
NCT07515664 is a Phase 4 study that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 20 participants.
The verdict
NCT07515664, a Phase 4 study, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a feasibility study of uninterrupted warfarin with a one time dose of Vitamin K before a surgical procedure.
Interventions
- DRUG Vitamin K
- DRUG Warfarin (standard without loading)
- DRUG Warfarin (standard with loading)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-03 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07515664
The ClinicalTrials.gov registry entry for NCT07515664 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Vitamin K is the first listed.
NCT07515664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07515664 about?
NCT07515664 is a clinical study titled "Vitamin K for Perioperative Warfarin Management". This is a feasibility study of uninterrupted warfarin with a one time dose of Vitamin K before a surgical procedure.
What is the current status of trial NCT07515664?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2025-07-03. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07515664?
The interventions under investigation include: Vitamin K (DRUG), Warfarin (standard without loading) (DRUG), Warfarin (standard with loading) (DRUG).
Who is sponsoring clinical trial NCT07515664?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.